Dr Sud Agarwal is an internationally recognised key opinion leader in the clinical use of cannabinoid medicines. Impression Healthcare (ASX: IHL) has tweaked its internal structure by appointing Dr Sud Agarwal, a leading figure in the medicinal cannabis industry as its Chief Medical Officer and non-executive director. The newly appointed executive is considered to be “one of the most influential people in the medicinal cannabis sector”, as evidenced by being a recent keynote speaker with Cannvalate at the World Cannabis Congress held in New Brunswick, Canada, and serving as an advisor to multiple public and private sector organisations on medicinal cannabis. Dr Agarwal’s background and expertise are therefore expected to be an instrumental piece of the puzzle for Impression as the company seeks to advance a number of commercially viable products spanning across multiple healthcare niches. Cannvalate has been working with Impression for a number of months supporting them […]